Literature DB >> 10597878

Transvaginal sonography and hysteroscopy in postmenopausal uterine bleeding.

G Loverro1, S Bettocchi, G Cormio, V Nicolardi, P Greco, A Vimercati, L Selvaggi.   

Abstract

OBJECTIVE: To compare the diagnostic accuracy of transvaginal ultrasound and hysteroscopy in the detection of endometrial pathologies in women with postmenopausal bleeding not using hormonal replacement therapy (HRT).
METHODS: Between January 1997 and April 1998, 106 postmenopausal women with uterine bleeding not using HRT underwent a diagnostic work-up including pelvic examination, transvaginal ultrasound, hysteroscopy and endometrial biopsy. Sonographic measurement of endometrial thickness and hysteroscopic findings were compared with histological results. The 'classification tree' method was used to identify cut-off values of sonographic endometrial thickness that could be indicative of a class of uterine pathology. Statistical analysis was performed with the McNemar test.
RESULTS: No case of endometrial cancer was found with a cut-off point of 5 mm of endometrial thickness evaluated by ultrasound, whereas all patients with endometrial thickness > or = 15 mm at sonography had an endometrial carcinoma. In the group of patients with endometrial thickness between 6 and 14 mm, we found normal atrophic endometria, benign and malignant pathology. On the other hand, the McNemar test showed a very good correspondence between hysteroscopy and histology (sensitivity 97.5% and specificity 100%), confirming its usefulness in diagnosis of postmenopausal uterine bleeding.
CONCLUSIONS: Transvaginal ultrasound has revealed some limitations, mainly in the group of patients with endometrial thickness between 6 and 14 mm. The absence of endometrial malignancy in women with endometrial thickness < or = 5 mm and the high possibility of cancer in those with endometrial thickness > or = 15 mm should be confirmed in larger series. Hysteroscopy proved to be a simple and safe outpatient procedure with a high diagnostic accuracy, and in our opinion it should be considered in all women with postmenopausal uterine bleeding.

Entities:  

Mesh:

Year:  1999        PMID: 10597878     DOI: 10.1016/s0378-5122(99)00023-7

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  6 in total

1.  Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding.

Authors:  Pushpa Singh; Pooja Dwivedi; Shweta Mendiratta
Journal:  J Obstet Gynaecol India       Date:  2014-11-04

2.  The efficacy, cost and patient satisfaction of classic versus office hysteroscopy in cases with suspected intrauterine space occupying lesions with 3-dimension ultrasound and abnormal uterine bleeding.

Authors:  Tarık Filiz; Emek Doğer; Aydın Corakçı; Semih Ozeren; Eray Calışkan
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-12-01

3.  Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.

Authors:  Megan A Clarke; Beverly J Long; Arena Del Mar Morillo; Marc Arbyn; Jamie N Bakkum-Gamez; Nicolas Wentzensen
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

Review 4.  Clinical evaluation of women with PMB. Is it always necessary an endometrial biopsy to be performed? A review of the literature.

Authors:  Marina Dimitraki; Panagiotis Tsikouras; Sophia Bouchlariotou; Alexandros Dafopoulos; Vasileios Liberis; Georgios Maroulis; Alexander Tobias Teichmann
Journal:  Arch Gynecol Obstet       Date:  2010-08-04       Impact factor: 2.344

5.  Addition of power Doppler to grey scale transvaginal ultrasonography for improving the prediction of endometrial pathology in perimenopausal women with abnormal uterine bleeding.

Authors:  P Veena; Dasabharathi Baskaran; Dilip Kumar Maurya; N S Kubera; Jayalakshmi Dorairaj
Journal:  Indian J Med Res       Date:  2018-09       Impact factor: 2.375

Review 6.  Preoperative assessment of endometrial cancer.

Authors:  Péter Török; Zoárd Krasznai; Szabolcs Molnár; Rudolf Lampé; Attila Jakab
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.